Bemnifosbuvir Hemisulfate (AT-527)

Abbreviation
BEM
Disease(s)
HCV
Background
.pdf
Patent oppositions filed in
India

Bemnifosbuvir is a prodrug of novel guanosine monophosphate analogue with pangenotypic antiviral activity.

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
India28-09-2022Sankalp Rehabilitation TrustPre-GrantGrantedCompositions201917029812View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top

Patent Office Decisions

This table showcases the final ruling of patent offices over cases where patents have been opposed.

To better identify the case, the number of the patent application is provided in the table below.

Decision typeCountryDatePatent officeRelated patent applicationMore info
RejectionIndia03-06-2024Indian Patent Office201917029812View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top